EOS Imaging has developed the EOS device, a novel 3D digital x-ray imaging system that offers a low dose and full body image of the skeletal structure, addressing unmet needs in orthopedic imaging field.

Stage invested in 2007, supporting the company through to an IPO on the NYSE Euronext stock market in February 2012.  The Fund retains a shareholding in the business.

Headquarters
France

INVESTMENT DATE
November 2007

INVESTMENT THESIS
Venture-stage investment in medical technology

STATUS
Current

INDUSTRY
Imaging

STAGE CAPITAL TEAM
Aris Constantinides